Using an in vitro assay system, polybrominated biphenyl (PBB) was assessed for its ability to inhibit metabolic cooperation between 6-thioguanine sensitive and resistant Chinese hamster V79 cells. Using a nonlethal range of the chemical, PBB was shown to inhibit metabolic cooperation (a form of cell-cell communication) in a manner similar to other known tumor promoters. Results suggest that PBB could carcinogenic promoter.
Introduction
Carcinogenesis in many animal test systems has been shown to be a complex and multistaged process (1) , consisting of initiation and promotion phases (2, 3) . Not only has this initiation/promotion concept of carcinogenesis been found in vivo in animals, but also it appears to explain the multistep processes of in vitro transformation (4) (5) (6) . Moreover, there are several reports which can lead one to believe that initiation and promotion phases exist in human carcinogenesis (7) (8) (9) (10) (11) .
Initiation is now thought to involve the induction of DNA damage and the error-prone repair or replication of that damage in mutation fixation (12) , whereas promotion seems to be the selective proliferation of the initiated cells by agents that affect cell membranes (i.e., tumor promoters) (13) (14) (15) (16) (17) Yotti et al. (18) , Trosko et al. (19) , and Murray and Fitzgerald (20) have shown that known tumor promoters blocked metabolic cooperation between cells in vitro. Although the mechanism by which tumor promoters block this form of cell-cell communication is not known, it is suspected that interference with gap-junction function (21) might be involved (18, 20) . Once cells escape the contactinhibiting (22) (29) has promoted a widespread number of studies on the potential biological consequences on human health. We report the results of our studies to test if PBB acts as other known tumor promoters in our in vitro assay using Chinese hamster cells.
Materials and Method
All cells used in the assay were originally derived from V79 Chinese hamster lung cells. The detailed protocol for the in vitro promoter assay has been reported (19) . Wild-type cells [6-thioguanine-sensitive, presumptive hypoxanthine guanine-phosphoribosyltransferase (HG-PRT +)] are seeded into 100 mm tissue culture dishes at a density of 9 x 105 cells per dish. Immediately after plating of wild-type cells, 100 6-thioguanine-resistant cells (HG-PRT-) are seeded in the same dishes. Both cell lines are given 4 hr for attachment, at which time the PBB (Velsicol Corp.; dissolved in acetone) is added directly into each individual dish. 6-Thioguanine (final concentration, 10 ,ug/ml) was added immediately after treatment with PBB. The cells were incubated for two days without interruption, at which time the medium was changed. PBB-eontaining medium was removed and growth continued on theselective medium. After another two days of growth, the medium was again replaced with fresh selective medium. Three more days of growth resulted in colonies of a size sufficient to score visually. The medium is decanted, each dish was rinsed with 0.85% saline; the plates were air-dried, fixed with 95% ethanol and stained with Giemsa. The resulting colonies were scored visually.
Results and Discussion
In order to determine the cytotoxicity of PBB, the experiment in Figure 1 As an extension of these results, we designed a dose-response experiment. Figure 2 demonstrates that there does seem to be a definite dose response curve from 2.5 ,ug/ml to 10 ,ug/ml. The data also suggest a threshold level, below which no inhibition of metabolic cooperation is detectable. It must also be stressed that the inhibition of metabolic cooperation that was observed was at levels which were nontoxic to the cells.
If we assume that carcinogenesis in human beings consists of initiation and promotion phases, that this in vitro assay to detect tumor promoters, using Environmental Health Perspectives PBB has been shown to reduce, significantly, the incidence of N-2-fluorenylacetamide-induced mammary gland and ear duct tumors in female rats (30) . Of importance is the observation that PBB has many properties similar to phenobarbital (31, 32) and butylated hydroxytoluene (31) (32) (33) (34) , in that these chemicals can inhibit chemically induced carcinogenesis if administered prior to the carcinogen, but they act as promoters when given after carcinogen exposure. These observations in animals, plus our in vitro results, lead us to believe that, i7l vivo, PBB could be a promoter of certain types of tumors under conditions where the organism has been previously initiated.
Furthermore, because of a recent in vitro assay for teratogens which is based on the ability of a chemical to affect cell membrane surface adhesion (35) , one might predict PBB could also be a teratogen. Since both our assay and the teratogen assay are dependent on specific membrane components, not all cells in all organs will be negatively affected by PBB (or any other chemical). However, this demonstration that PBB does affect a cell type, in a manner similar to a wide number of other known promoters (i.e., saccharin, DDT, Tween 60, phenobarbital, etc.) (19) , forms the basis for additional experiments, in animals, to verify both the promotion and teratogen potential of PBB.
